agilon health, inc. (AGL)
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Every figure as a table ›
Revenue Quarterly
0
600M
1.2B
1.8B
Q3 '21: 458.6M
Q4 '21: 150.8M
Q1 '22: 653.4M
Q2 '22: 670.1M
Q3 '22: 694.9M
Q4 '22: 369.8M
Q1 '23: 1.1B
Q2 '23: 1.1B
Q3 '23: 1.1B
Q4 '23: 1.1B
Q1 '24: 1.6B
Q2 '24: 1.5B
Q3 '24: 1.5B
Q4 '24: 1.5B
Q1 '25: 1.5B
Q2 '25: 1.4B
Q3 '25: 1.4B
Q4 '25: 1.6B
Q1 '26: 1.4B
Q2 '26: 1.5B
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Income Quarterly
-210M
-140M
-70M
0
70M
140M
210M
Q3 '21: -35.6M
Q4 '21: -26.2M
Q1 '22: -743K
Q2 '22: -21.1M
Q3 '22: -29.5M
Q4 '22: -54.1M
Q1 '23: 417K
Q2 '23: -29M
Q3 '23: -39.3M
Q4 '23: -164.3M
Q1 '24: -7.2M
Q2 '24: -43.3M
Q3 '24: -133.5M
Q4 '24: -108.1M
Q1 '25: -22.1M
Q2 '25: -116M
Q3 '25: -131.3M
Q4 '25: -193.8M
Q1 '26: 4M
Q2 '26: 11.8M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income Quarterly
-240M
-160M
-80M
0
80M
160M
240M
Q3 '21: -35.8M
Q4 '21: -56.7M
Q1 '22: 1.2M
Q2 '22: -20.6M
Q3 '22: -30.7M
Q4 '22: -56.5M
Q1 '23: 16M
Q2 '23: -16.7M
Q3 '23: -31.4M
Q4 '23: -230.4M
Q1 '24: -6.1M
Q2 '24: -30.7M
Q3 '24: -117.6M
Q4 '24: -105.8M
Q1 '25: 12.1M
Q2 '25: -104.4M
Q3 '25: -110.2M
Q4 '25: -188.9M
Q1 '26: 48.9M
Q2 '26: 18M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Cash Flow Quarterly
-75M
-50M
-25M
0
25M
50M
75M
Q3 '21: -19.1M
Q4 '21: -48.9M
Q1 '22: -23.2M
Q2 '22: -60.3M
Q3 '22: 2.6M
Q4 '22: -50M
Q1 '23: -60.8M
Q2 '23: -21.2M
Q3 '23: -13M
Q4 '23: -61.2M
Q1 '24: -47.8M
Q2 '24: -18.7M
Q3 '24: -7.7M
Q4 '24: 16.4M
Q1 '25: -32M
Q2 '25: -35.1M
Q3 '25: -18.2M
Q4 '25: -20.5M
Q1 '26: 23.7M
Q2 '26: -57.3M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow Quarterly
-75M
-50M
-25M
0
25M
50M
75M
Q3 '21: -21.7M
Q4 '21: -52.3M
Q1 '22: -27.3M
Q2 '22: -64.7M
Q3 '22: -786K
Q4 '22: -53.4M
Q1 '23: -64.5M
Q2 '23: -25.3M
Q3 '23: -17.1M
Q4 '23: -65.1M
Q1 '24: -50.9M
Q2 '24: -22M
Q3 '24: -11.2M
Q4 '24: 13.2M
Q1 '25: -35.8M
Q2 '25: -38.3M
Q3 '25: -21.3M
Q4 '25: -23.5M
Q1 '26: 20.6M
Q2 '26: -60.7M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
150M
300M
450M
Q1 '21: 325.7M
Q2 '21: 377.4M
Q3 '21: 391.2M
Q1 '22: 424.1M
Q2 '22: 407.3M
Q3 '22: 411.1M
Q1 '23: 426.6M
Q2 '23: 410.3M
Q3 '23: 405.8M
Q1 '24: 408.9M
Q2 '24: 411.3M
Q3 '24: 411.6M
Q1 '25: 16.5M
Q2 '25: 16.6M
Q3 '25: 414.5M
Q1 '26: 16.7M
Q2 '26: 17.2M
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
Not drawn for AGL:
Gross Profit, Cost of Revenue, EPS . Nothing in this filer's XBRL supports
them for the periods asked for. That is a gap in
the filing, not a zero, and drawing a flat line would be an invention.